nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—Nonsteroidal Anti-inflammatory Compounds—Acetylsalicylic acid—coronary artery disease	0.287	1	CiPCiCtD
Naproxen—Indomethacin—Fenofibrate—coronary artery disease	0.142	1	CrCrCtD
Naproxen—systemic lupus erythematosus—Acetylsalicylic acid—coronary artery disease	0.0845	0.444	CpDpCtD
Naproxen—rheumatoid arthritis—Acetylsalicylic acid—coronary artery disease	0.0436	0.229	CpDpCtD
Naproxen—PTGS2—coronary artery disease	0.0327	0.529	CbGaD
Naproxen—migraine—Acetylsalicylic acid—coronary artery disease	0.0315	0.166	CpDpCtD
Naproxen—osteoarthritis—Acetylsalicylic acid—coronary artery disease	0.0305	0.16	CpDpCtD
Naproxen—ALB—coronary artery disease	0.0292	0.471	CbGaD
Naproxen—UGT2B7—Pitavastatin—coronary artery disease	0.0115	0.0537	CbGbCtD
Naproxen—UGT2B7—Ezetimibe—coronary artery disease	0.00844	0.0396	CbGbCtD
Naproxen—UGT2B7—Simvastatin—coronary artery disease	0.00785	0.0368	CbGbCtD
Naproxen—UGT2B7—Lovastatin—coronary artery disease	0.00768	0.036	CbGbCtD
Naproxen—UGT1A1—Ezetimibe—coronary artery disease	0.0073	0.0342	CbGbCtD
Naproxen—UGT2B7—Atorvastatin—coronary artery disease	0.007	0.0328	CbGbCtD
Naproxen—SLCO1A2—Enalapril—coronary artery disease	0.00689	0.0323	CbGbCtD
Naproxen—UGT1A1—Simvastatin—coronary artery disease	0.00678	0.0318	CbGbCtD
Naproxen—UGT1A1—Lovastatin—coronary artery disease	0.00664	0.0311	CbGbCtD
Naproxen—UGT2B7—Losartan—coronary artery disease	0.0064	0.03	CbGbCtD
Naproxen—UGT1A1—Atorvastatin—coronary artery disease	0.00605	0.0284	CbGbCtD
Naproxen—UGT1A1—Losartan—coronary artery disease	0.00553	0.0259	CbGbCtD
Naproxen—SLCO1A2—Rosuvastatin—coronary artery disease	0.00535	0.0251	CbGbCtD
Naproxen—SLCO1A2—Simvastatin—coronary artery disease	0.00498	0.0233	CbGbCtD
Naproxen—SLCO1A2—Pravastatin—coronary artery disease	0.00487	0.0228	CbGbCtD
Naproxen—SLCO1A2—Lovastatin—coronary artery disease	0.00487	0.0228	CbGbCtD
Naproxen—CYP2C8—Fenofibrate—coronary artery disease	0.00479	0.0224	CbGbCtD
Naproxen—SLCO1A2—Atorvastatin—coronary artery disease	0.00444	0.0208	CbGbCtD
Naproxen—PTGS2—Acetylsalicylic acid—coronary artery disease	0.00427	0.02	CbGbCtD
Naproxen—SLC22A6—Enalapril—coronary artery disease	0.00418	0.0196	CbGbCtD
Naproxen—CYP2C8—Gemfibrozil—coronary artery disease	0.00383	0.0179	CbGbCtD
Naproxen—ALB—Pitavastatin—coronary artery disease	0.00375	0.0176	CbGbCtD
Naproxen—ALB—Valsartan—coronary artery disease	0.00365	0.0171	CbGbCtD
Naproxen—PTGS1—Acetylsalicylic acid—coronary artery disease	0.00361	0.0169	CbGbCtD
Naproxen—CYP2C9—Fenofibrate—coronary artery disease	0.00334	0.0157	CbGbCtD
Naproxen—CYP2C8—Clopidogrel—coronary artery disease	0.00332	0.0156	CbGbCtD
Naproxen—SLC22A6—Acetylsalicylic acid—coronary artery disease	0.00317	0.0148	CbGbCtD
Naproxen—SLC22A6—Captopril—coronary artery disease	0.00313	0.0147	CbGbCtD
Naproxen—CYP1A2—Gemfibrozil—coronary artery disease	0.00296	0.0139	CbGbCtD
Naproxen—SLC22A6—Pravastatin—coronary artery disease	0.00296	0.0139	CbGbCtD
Naproxen—CYP2C8—Pitavastatin—coronary artery disease	0.0029	0.0136	CbGbCtD
Naproxen—ALB—Rosuvastatin—coronary artery disease	0.00277	0.013	CbGbCtD
Naproxen—ALB—Acetylsalicylic acid—coronary artery disease	0.0027	0.0126	CbGbCtD
Naproxen—CYP2C9—Gemfibrozil—coronary artery disease	0.00267	0.0125	CbGbCtD
Naproxen—ALB—Captopril—coronary artery disease	0.00266	0.0125	CbGbCtD
Naproxen—CYP1A2—Clopidogrel—coronary artery disease	0.00257	0.012	CbGbCtD
Naproxen—SLC22A6—Furosemide—coronary artery disease	0.00251	0.0118	CbGbCtD
Naproxen—SLC22A6—Losartan—coronary artery disease	0.00246	0.0115	CbGbCtD
Naproxen—CYP2C9—Clopidogrel—coronary artery disease	0.00231	0.0109	CbGbCtD
Naproxen—ALB—Furosemide—coronary artery disease	0.00214	0.01	CbGbCtD
Naproxen—ALB—Losartan—coronary artery disease	0.0021	0.00983	CbGbCtD
Naproxen—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00208	0.00977	CbGbCtD
Naproxen—CYP2C9—Pitavastatin—coronary artery disease	0.00202	0.00948	CbGbCtD
Naproxen—CYP2C8—Simvastatin—coronary artery disease	0.00199	0.00932	CbGbCtD
Naproxen—CYP2C9—Valsartan—coronary artery disease	0.00197	0.00923	CbGbCtD
Naproxen—CYP2C8—Lovastatin—coronary artery disease	0.00194	0.00912	CbGbCtD
Naproxen—CYP2C8—Pravastatin—coronary artery disease	0.00194	0.00912	CbGbCtD
Naproxen—CYP2C8—Atorvastatin—coronary artery disease	0.00177	0.00831	CbGbCtD
Naproxen—CYP2C8—Losartan—coronary artery disease	0.00162	0.0076	CbGbCtD
Naproxen—CYP2C9—Rosuvastatin—coronary artery disease	0.00149	0.00699	CbGbCtD
Naproxen—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00145	0.00681	CbGbCtD
Naproxen—CYP2C9—Simvastatin—coronary artery disease	0.00139	0.0065	CbGbCtD
Naproxen—CYP2C9—Lovastatin—coronary artery disease	0.00136	0.00636	CbGbCtD
Naproxen—CYP2C9—Pravastatin—coronary artery disease	0.00136	0.00636	CbGbCtD
Naproxen—CYP2C9—cardial valve—coronary artery disease	0.00132	0.323	CbGeAlD
Naproxen—CYP1A2—Losartan—coronary artery disease	0.00125	0.00588	CbGbCtD
Naproxen—CYP2C9—Atorvastatin—coronary artery disease	0.00124	0.00579	CbGbCtD
Naproxen—CYP2C9—Losartan—coronary artery disease	0.00113	0.0053	CbGbCtD
Naproxen—AKR1C3—cardiac ventricle—coronary artery disease	0.000286	0.0702	CbGeAlD
Naproxen—AKR1C3—myocardium—coronary artery disease	0.000269	0.0661	CbGeAlD
Naproxen—Indomethacin—PLA2G2A—coronary artery disease	0.00022	0.155	CrCbGaD
Naproxen—AKR1C3—heart—coronary artery disease	0.000188	0.0461	CbGeAlD
Naproxen—PTGS1—artery—coronary artery disease	0.00018	0.0443	CbGeAlD
Naproxen—PTGS2—artery—coronary artery disease	0.000173	0.0423	CbGeAlD
Naproxen—Ibuprofen—THBD—coronary artery disease	0.000163	0.115	CrCbGaD
Naproxen—AKR1C3—cardiac atrium—coronary artery disease	0.000161	0.0394	CbGeAlD
Naproxen—PTGS1—endothelium—coronary artery disease	0.000152	0.0374	CbGeAlD
Naproxen—PTGS2—endothelium—coronary artery disease	0.000146	0.0358	CbGeAlD
Naproxen—AKR1C3—blood—coronary artery disease	0.00014	0.0344	CbGeAlD
Naproxen—Nabumetone—MPO—coronary artery disease	0.000136	0.0956	CrCbGaD
Naproxen—UGT1A1—blood—coronary artery disease	0.000129	0.0317	CbGeAlD
Naproxen—Ibuprofen—CFTR—coronary artery disease	0.000117	0.0825	CrCbGaD
Naproxen—ALB—heart—coronary artery disease	0.000117	0.0286	CbGeAlD
Naproxen—Ibuprofen—PLAT—coronary artery disease	0.000112	0.0787	CrCbGaD
Naproxen—PTGS1—myocardium—coronary artery disease	9.52e-05	0.0234	CbGeAlD
Naproxen—CYP2C9—heart—coronary artery disease	7.28e-05	0.0179	CbGeAlD
Naproxen—CYP2C9—cardiovascular system—coronary artery disease	6.87e-05	0.0169	CbGeAlD
Naproxen—PTGS1—heart—coronary artery disease	6.65e-05	0.0163	CbGeAlD
Naproxen—Indomethacin—CXCL8—coronary artery disease	6.53e-05	0.046	CrCbGaD
Naproxen—Ibuprofen—BCL2—coronary artery disease	6.41e-05	0.0452	CrCbGaD
Naproxen—PTGS2—heart—coronary artery disease	6.35e-05	0.0156	CbGeAlD
Naproxen—PTGS1—cardiovascular system—coronary artery disease	6.27e-05	0.0154	CbGeAlD
Naproxen—CYP2C8—blood—coronary artery disease	6.12e-05	0.015	CbGeAlD
Naproxen—PTGS2—cardiovascular system—coronary artery disease	5.99e-05	0.0147	CbGeAlD
Naproxen—CYP1A2—blood—coronary artery disease	5.72e-05	0.014	CbGeAlD
Naproxen—PTGS1—cardiac atrium—coronary artery disease	5.68e-05	0.014	CbGeAlD
Naproxen—CYP2C9—blood—coronary artery disease	5.43e-05	0.0133	CbGeAlD
Naproxen—Ketoprofen—CXCL8—coronary artery disease	5.22e-05	0.0368	CrCbGaD
Naproxen—Ibuprofen—CXCL8—coronary artery disease	5.14e-05	0.0362	CrCbGaD
Naproxen—Nabumetone—PTGS2—coronary artery disease	5.08e-05	0.0358	CrCbGaD
Naproxen—PTGS1—blood—coronary artery disease	4.96e-05	0.0122	CbGeAlD
Naproxen—Carprofen—PTGS2—coronary artery disease	4.85e-05	0.0342	CrCbGaD
Naproxen—PTGS2—blood—coronary artery disease	4.74e-05	0.0116	CbGeAlD
Naproxen—Indomethacin—PPARG—coronary artery disease	4.51e-05	0.0318	CrCbGaD
Naproxen—Ibuprofen—PPARG—coronary artery disease	3.55e-05	0.025	CrCbGaD
Naproxen—Indomethacin—CYP2C19—coronary artery disease	3.06e-05	0.0216	CrCbGaD
Naproxen—Suprofen—PTGS2—coronary artery disease	3e-05	0.0211	CrCbGaD
Naproxen—Fenoprofen—PTGS2—coronary artery disease	2.58e-05	0.0182	CrCbGaD
Naproxen—Ibuprofen—CYP2C19—coronary artery disease	2.41e-05	0.017	CrCbGaD
Naproxen—Fenoprofen—ALB—coronary artery disease	2.3e-05	0.0162	CrCbGaD
Naproxen—Indomethacin—PTGS2—coronary artery disease	1.91e-05	0.0134	CrCbGaD
Naproxen—Indomethacin—ALB—coronary artery disease	1.7e-05	0.012	CrCbGaD
Naproxen—Flurbiprofen—PTGS2—coronary artery disease	1.68e-05	0.0119	CrCbGaD
Naproxen—Ketoprofen—PTGS2—coronary artery disease	1.52e-05	0.0107	CrCbGaD
Naproxen—Flurbiprofen—ALB—coronary artery disease	1.5e-05	0.0106	CrCbGaD
Naproxen—Ibuprofen—PTGS2—coronary artery disease	1.5e-05	0.0106	CrCbGaD
Naproxen—Ketoprofen—ALB—coronary artery disease	1.36e-05	0.00957	CrCbGaD
Naproxen—Ibuprofen—ALB—coronary artery disease	1.34e-05	0.00942	CrCbGaD
Naproxen—Malaise—Lisinopril—coronary artery disease	1.05e-05	0.000151	CcSEcCtD
Naproxen—Anaphylactic shock—Ramipril—coronary artery disease	1.05e-05	0.00015	CcSEcCtD
Naproxen—Oedema—Ramipril—coronary artery disease	1.05e-05	0.00015	CcSEcCtD
Naproxen—Vertigo—Lisinopril—coronary artery disease	1.05e-05	0.00015	CcSEcCtD
Naproxen—Dry mouth—Timolol—coronary artery disease	1.04e-05	0.00015	CcSEcCtD
Naproxen—Pain—Losartan—coronary artery disease	1.04e-05	0.00015	CcSEcCtD
Naproxen—Constipation—Losartan—coronary artery disease	1.04e-05	0.00015	CcSEcCtD
Naproxen—Syncope—Lisinopril—coronary artery disease	1.04e-05	0.00015	CcSEcCtD
Naproxen—Vomiting—Eplerenone—coronary artery disease	1.04e-05	0.00015	CcSEcCtD
Naproxen—Feeling abnormal—Furosemide—coronary artery disease	1.04e-05	0.00015	CcSEcCtD
Naproxen—Leukopenia—Lisinopril—coronary artery disease	1.04e-05	0.00015	CcSEcCtD
Naproxen—Nausea—Fenofibrate—coronary artery disease	1.04e-05	0.000149	CcSEcCtD
Naproxen—Pruritus—Niacin—coronary artery disease	1.04e-05	0.000149	CcSEcCtD
Naproxen—Asthenia—Pravastatin—coronary artery disease	1.04e-05	0.000149	CcSEcCtD
Naproxen—Gastrointestinal pain—Furosemide—coronary artery disease	1.04e-05	0.000149	CcSEcCtD
Naproxen—Rash—Eplerenone—coronary artery disease	1.03e-05	0.000149	CcSEcCtD
Naproxen—Urticaria—Perindopril—coronary artery disease	1.03e-05	0.000149	CcSEcCtD
Naproxen—Hypersensitivity—Trandolapril—coronary artery disease	1.03e-05	0.000149	CcSEcCtD
Naproxen—Dermatitis—Eplerenone—coronary artery disease	1.03e-05	0.000148	CcSEcCtD
Naproxen—Diarrhoea—Valsartan—coronary artery disease	1.03e-05	0.000148	CcSEcCtD
Naproxen—Confusional state—Timolol—coronary artery disease	1.03e-05	0.000148	CcSEcCtD
Naproxen—Shock—Ramipril—coronary artery disease	1.03e-05	0.000148	CcSEcCtD
Naproxen—Hypersensitivity—Enalapril—coronary artery disease	1.03e-05	0.000148	CcSEcCtD
Naproxen—Abdominal pain—Perindopril—coronary artery disease	1.03e-05	0.000148	CcSEcCtD
Naproxen—Body temperature increased—Perindopril—coronary artery disease	1.03e-05	0.000148	CcSEcCtD
Naproxen—Palpitations—Lisinopril—coronary artery disease	1.03e-05	0.000148	CcSEcCtD
Naproxen—Diarrhoea—Olmesartan—coronary artery disease	1.03e-05	0.000148	CcSEcCtD
Naproxen—Headache—Eplerenone—coronary artery disease	1.03e-05	0.000148	CcSEcCtD
Naproxen—Nervous system disorder—Ramipril—coronary artery disease	1.03e-05	0.000147	CcSEcCtD
Naproxen—Thrombocytopenia—Ramipril—coronary artery disease	1.03e-05	0.000147	CcSEcCtD
Naproxen—Anaphylactic shock—Timolol—coronary artery disease	1.02e-05	0.000147	CcSEcCtD
Naproxen—Oedema—Timolol—coronary artery disease	1.02e-05	0.000147	CcSEcCtD
Naproxen—Pruritus—Pravastatin—coronary artery disease	1.02e-05	0.000147	CcSEcCtD
Naproxen—Loss of consciousness—Lisinopril—coronary artery disease	1.02e-05	0.000147	CcSEcCtD
Naproxen—Nausea—Clopidogrel—coronary artery disease	1.02e-05	0.000147	CcSEcCtD
Naproxen—Tachycardia—Ramipril—coronary artery disease	1.02e-05	0.000147	CcSEcCtD
Naproxen—Skin disorder—Ramipril—coronary artery disease	1.02e-05	0.000146	CcSEcCtD
Naproxen—Infection—Timolol—coronary artery disease	1.02e-05	0.000146	CcSEcCtD
Naproxen—Vomiting—Simvastatin—coronary artery disease	1.02e-05	0.000146	CcSEcCtD
Naproxen—Hypersensitivity—Telmisartan—coronary artery disease	1.02e-05	0.000146	CcSEcCtD
Naproxen—Cough—Lisinopril—coronary artery disease	1.02e-05	0.000146	CcSEcCtD
Naproxen—Nausea—Lovastatin—coronary artery disease	1.02e-05	0.000146	CcSEcCtD
Naproxen—Hyperhidrosis—Ramipril—coronary artery disease	1.01e-05	0.000145	CcSEcCtD
Naproxen—Rash—Simvastatin—coronary artery disease	1.01e-05	0.000145	CcSEcCtD
Naproxen—Dermatitis—Simvastatin—coronary artery disease	1.01e-05	0.000145	CcSEcCtD
Naproxen—Asthenia—Trandolapril—coronary artery disease	1.01e-05	0.000145	CcSEcCtD
Naproxen—Shock—Timolol—coronary artery disease	1.01e-05	0.000145	CcSEcCtD
Naproxen—Feeling abnormal—Losartan—coronary artery disease	1.01e-05	0.000145	CcSEcCtD
Naproxen—Urticaria—Furosemide—coronary artery disease	1.01e-05	0.000144	CcSEcCtD
Naproxen—Diarrhoea—Niacin—coronary artery disease	1e-05	0.000144	CcSEcCtD
Naproxen—Nervous system disorder—Timolol—coronary artery disease	1e-05	0.000144	CcSEcCtD
Naproxen—Asthenia—Enalapril—coronary artery disease	1e-05	0.000144	CcSEcCtD
Naproxen—Headache—Simvastatin—coronary artery disease	1e-05	0.000144	CcSEcCtD
Naproxen—Abdominal pain—Furosemide—coronary artery disease	1e-05	0.000144	CcSEcCtD
Naproxen—Body temperature increased—Furosemide—coronary artery disease	1e-05	0.000144	CcSEcCtD
Naproxen—Gastrointestinal pain—Losartan—coronary artery disease	9.99e-06	0.000143	CcSEcCtD
Naproxen—Dizziness—Valsartan—coronary artery disease	9.99e-06	0.000143	CcSEcCtD
Naproxen—Anorexia—Ramipril—coronary artery disease	9.98e-06	0.000143	CcSEcCtD
Naproxen—Nausea—Ezetimibe—coronary artery disease	9.96e-06	0.000143	CcSEcCtD
Naproxen—Skin disorder—Timolol—coronary artery disease	9.95e-06	0.000143	CcSEcCtD
Naproxen—Dizziness—Olmesartan—coronary artery disease	9.94e-06	0.000143	CcSEcCtD
Naproxen—Pruritus—Trandolapril—coronary artery disease	9.93e-06	0.000143	CcSEcCtD
Naproxen—Chest pain—Lisinopril—coronary artery disease	9.91e-06	0.000142	CcSEcCtD
Naproxen—Arthralgia—Lisinopril—coronary artery disease	9.91e-06	0.000142	CcSEcCtD
Naproxen—Myalgia—Lisinopril—coronary artery disease	9.91e-06	0.000142	CcSEcCtD
Naproxen—Hyperhidrosis—Timolol—coronary artery disease	9.9e-06	0.000142	CcSEcCtD
Naproxen—Asthenia—Telmisartan—coronary artery disease	9.9e-06	0.000142	CcSEcCtD
Naproxen—Pruritus—Enalapril—coronary artery disease	9.89e-06	0.000142	CcSEcCtD
Naproxen—Diarrhoea—Pravastatin—coronary artery disease	9.89e-06	0.000142	CcSEcCtD
Naproxen—Anxiety—Lisinopril—coronary artery disease	9.87e-06	0.000142	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	9.84e-06	0.000141	CcSEcCtD
Naproxen—Discomfort—Lisinopril—coronary artery disease	9.79e-06	0.000141	CcSEcCtD
Naproxen—Hypotension—Ramipril—coronary artery disease	9.79e-06	0.000141	CcSEcCtD
Naproxen—Anorexia—Timolol—coronary artery disease	9.76e-06	0.00014	CcSEcCtD
Naproxen—Pruritus—Telmisartan—coronary artery disease	9.76e-06	0.00014	CcSEcCtD
Naproxen—Nausea—Eplerenone—coronary artery disease	9.75e-06	0.00014	CcSEcCtD
Naproxen—Dizziness—Niacin—coronary artery disease	9.71e-06	0.000139	CcSEcCtD
Naproxen—Urticaria—Losartan—coronary artery disease	9.7e-06	0.000139	CcSEcCtD
Naproxen—Dry mouth—Lisinopril—coronary artery disease	9.69e-06	0.000139	CcSEcCtD
Naproxen—Abdominal pain—Losartan—coronary artery disease	9.66e-06	0.000139	CcSEcCtD
Naproxen—Body temperature increased—Losartan—coronary artery disease	9.66e-06	0.000139	CcSEcCtD
Naproxen—Asthenia—Captopril—coronary artery disease	9.62e-06	0.000138	CcSEcCtD
Naproxen—Diarrhoea—Trandolapril—coronary artery disease	9.61e-06	0.000138	CcSEcCtD
Naproxen—Vomiting—Valsartan—coronary artery disease	9.6e-06	0.000138	CcSEcCtD
Naproxen—Confusional state—Lisinopril—coronary artery disease	9.58e-06	0.000138	CcSEcCtD
Naproxen—Diarrhoea—Enalapril—coronary artery disease	9.57e-06	0.000137	CcSEcCtD
Naproxen—Hypotension—Timolol—coronary artery disease	9.57e-06	0.000137	CcSEcCtD
Naproxen—Dizziness—Pravastatin—coronary artery disease	9.56e-06	0.000137	CcSEcCtD
Naproxen—Vomiting—Olmesartan—coronary artery disease	9.56e-06	0.000137	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Ramipril—coronary artery disease	9.54e-06	0.000137	CcSEcCtD
Naproxen—Rash—Valsartan—coronary artery disease	9.52e-06	0.000137	CcSEcCtD
Naproxen—Dermatitis—Valsartan—coronary artery disease	9.51e-06	0.000137	CcSEcCtD
Naproxen—Nausea—Simvastatin—coronary artery disease	9.5e-06	0.000136	CcSEcCtD
Naproxen—Anaphylactic shock—Lisinopril—coronary artery disease	9.5e-06	0.000136	CcSEcCtD
Naproxen—Oedema—Lisinopril—coronary artery disease	9.5e-06	0.000136	CcSEcCtD
Naproxen—Pruritus—Captopril—coronary artery disease	9.49e-06	0.000136	CcSEcCtD
Naproxen—Rash—Olmesartan—coronary artery disease	9.48e-06	0.000136	CcSEcCtD
Naproxen—Insomnia—Ramipril—coronary artery disease	9.47e-06	0.000136	CcSEcCtD
Naproxen—Dermatitis—Olmesartan—coronary artery disease	9.47e-06	0.000136	CcSEcCtD
Naproxen—Headache—Valsartan—coronary artery disease	9.46e-06	0.000136	CcSEcCtD
Naproxen—Diarrhoea—Telmisartan—coronary artery disease	9.44e-06	0.000136	CcSEcCtD
Naproxen—Infection—Lisinopril—coronary artery disease	9.44e-06	0.000136	CcSEcCtD
Naproxen—Headache—Olmesartan—coronary artery disease	9.42e-06	0.000135	CcSEcCtD
Naproxen—Paraesthesia—Ramipril—coronary artery disease	9.4e-06	0.000135	CcSEcCtD
Naproxen—Shock—Lisinopril—coronary artery disease	9.34e-06	0.000134	CcSEcCtD
Naproxen—Asthenia—Perindopril—coronary artery disease	9.34e-06	0.000134	CcSEcCtD
Naproxen—Dyspnoea—Ramipril—coronary artery disease	9.34e-06	0.000134	CcSEcCtD
Naproxen—Vomiting—Niacin—coronary artery disease	9.34e-06	0.000134	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Timolol—coronary artery disease	9.33e-06	0.000134	CcSEcCtD
Naproxen—Hypersensitivity—Furosemide—coronary artery disease	9.33e-06	0.000134	CcSEcCtD
Naproxen—Somnolence—Ramipril—coronary artery disease	9.31e-06	0.000134	CcSEcCtD
Naproxen—Thrombocytopenia—Lisinopril—coronary artery disease	9.3e-06	0.000134	CcSEcCtD
Naproxen—Dizziness—Trandolapril—coronary artery disease	9.28e-06	0.000133	CcSEcCtD
Naproxen—Tachycardia—Lisinopril—coronary artery disease	9.27e-06	0.000133	CcSEcCtD
Naproxen—Insomnia—Timolol—coronary artery disease	9.26e-06	0.000133	CcSEcCtD
Naproxen—Rash—Niacin—coronary artery disease	9.26e-06	0.000133	CcSEcCtD
Naproxen—Dermatitis—Niacin—coronary artery disease	9.25e-06	0.000133	CcSEcCtD
Naproxen—Dizziness—Enalapril—coronary artery disease	9.25e-06	0.000133	CcSEcCtD
Naproxen—Skin disorder—Lisinopril—coronary artery disease	9.23e-06	0.000132	CcSEcCtD
Naproxen—Dyspepsia—Ramipril—coronary artery disease	9.22e-06	0.000132	CcSEcCtD
Naproxen—Pruritus—Perindopril—coronary artery disease	9.21e-06	0.000132	CcSEcCtD
Naproxen—Headache—Niacin—coronary artery disease	9.2e-06	0.000132	CcSEcCtD
Naproxen—Paraesthesia—Timolol—coronary artery disease	9.19e-06	0.000132	CcSEcCtD
Naproxen—Vomiting—Pravastatin—coronary artery disease	9.19e-06	0.000132	CcSEcCtD
Naproxen—Hyperhidrosis—Lisinopril—coronary artery disease	9.18e-06	0.000132	CcSEcCtD
Naproxen—Diarrhoea—Captopril—coronary artery disease	9.18e-06	0.000132	CcSEcCtD
Naproxen—Dyspnoea—Timolol—coronary artery disease	9.13e-06	0.000131	CcSEcCtD
Naproxen—Dizziness—Telmisartan—coronary artery disease	9.12e-06	0.000131	CcSEcCtD
Naproxen—Rash—Pravastatin—coronary artery disease	9.12e-06	0.000131	CcSEcCtD
Naproxen—Dermatitis—Pravastatin—coronary artery disease	9.11e-06	0.000131	CcSEcCtD
Naproxen—Decreased appetite—Ramipril—coronary artery disease	9.1e-06	0.000131	CcSEcCtD
Naproxen—Somnolence—Timolol—coronary artery disease	9.1e-06	0.000131	CcSEcCtD
Naproxen—Asthenia—Furosemide—coronary artery disease	9.08e-06	0.00013	CcSEcCtD
Naproxen—Headache—Pravastatin—coronary artery disease	9.06e-06	0.00013	CcSEcCtD
Naproxen—Anorexia—Lisinopril—coronary artery disease	9.05e-06	0.00013	CcSEcCtD
Naproxen—Gastrointestinal disorder—Ramipril—coronary artery disease	9.04e-06	0.00013	CcSEcCtD
Naproxen—Fatigue—Ramipril—coronary artery disease	9.03e-06	0.00013	CcSEcCtD
Naproxen—Dyspepsia—Timolol—coronary artery disease	9.01e-06	0.000129	CcSEcCtD
Naproxen—Hypersensitivity—Losartan—coronary artery disease	9e-06	0.000129	CcSEcCtD
Naproxen—Nausea—Valsartan—coronary artery disease	8.97e-06	0.000129	CcSEcCtD
Naproxen—Pruritus—Furosemide—coronary artery disease	8.96e-06	0.000129	CcSEcCtD
Naproxen—Constipation—Ramipril—coronary artery disease	8.96e-06	0.000129	CcSEcCtD
Naproxen—Nausea—Olmesartan—coronary artery disease	8.93e-06	0.000128	CcSEcCtD
Naproxen—Vomiting—Trandolapril—coronary artery disease	8.93e-06	0.000128	CcSEcCtD
Naproxen—Diarrhoea—Perindopril—coronary artery disease	8.91e-06	0.000128	CcSEcCtD
Naproxen—Decreased appetite—Timolol—coronary artery disease	8.9e-06	0.000128	CcSEcCtD
Naproxen—Vomiting—Enalapril—coronary artery disease	8.89e-06	0.000128	CcSEcCtD
Naproxen—Hypotension—Lisinopril—coronary artery disease	8.88e-06	0.000127	CcSEcCtD
Naproxen—Dizziness—Captopril—coronary artery disease	8.87e-06	0.000127	CcSEcCtD
Naproxen—Rash—Trandolapril—coronary artery disease	8.85e-06	0.000127	CcSEcCtD
Naproxen—Dermatitis—Trandolapril—coronary artery disease	8.84e-06	0.000127	CcSEcCtD
Naproxen—Gastrointestinal disorder—Timolol—coronary artery disease	8.84e-06	0.000127	CcSEcCtD
Naproxen—Fatigue—Timolol—coronary artery disease	8.83e-06	0.000127	CcSEcCtD
Naproxen—Rash—Enalapril—coronary artery disease	8.82e-06	0.000127	CcSEcCtD
Naproxen—Dermatitis—Enalapril—coronary artery disease	8.81e-06	0.000126	CcSEcCtD
Naproxen—Headache—Trandolapril—coronary artery disease	8.8e-06	0.000126	CcSEcCtD
Naproxen—Vomiting—Telmisartan—coronary artery disease	8.77e-06	0.000126	CcSEcCtD
Naproxen—Asthenia—Losartan—coronary artery disease	8.76e-06	0.000126	CcSEcCtD
Naproxen—Headache—Enalapril—coronary artery disease	8.76e-06	0.000126	CcSEcCtD
Naproxen—Pain—Timolol—coronary artery disease	8.76e-06	0.000126	CcSEcCtD
Naproxen—Nausea—Niacin—coronary artery disease	8.72e-06	0.000125	CcSEcCtD
Naproxen—Rash—Telmisartan—coronary artery disease	8.7e-06	0.000125	CcSEcCtD
Naproxen—Dermatitis—Telmisartan—coronary artery disease	8.69e-06	0.000125	CcSEcCtD
Naproxen—Diarrhoea—Furosemide—coronary artery disease	8.66e-06	0.000124	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Lisinopril—coronary artery disease	8.65e-06	0.000124	CcSEcCtD
Naproxen—Pruritus—Losartan—coronary artery disease	8.64e-06	0.000124	CcSEcCtD
Naproxen—Headache—Telmisartan—coronary artery disease	8.64e-06	0.000124	CcSEcCtD
Naproxen—Feeling abnormal—Ramipril—coronary artery disease	8.63e-06	0.000124	CcSEcCtD
Naproxen—Dizziness—Perindopril—coronary artery disease	8.61e-06	0.000124	CcSEcCtD
Naproxen—Insomnia—Lisinopril—coronary artery disease	8.59e-06	0.000123	CcSEcCtD
Naproxen—Nausea—Pravastatin—coronary artery disease	8.59e-06	0.000123	CcSEcCtD
Naproxen—Gastrointestinal pain—Ramipril—coronary artery disease	8.56e-06	0.000123	CcSEcCtD
Naproxen—Paraesthesia—Lisinopril—coronary artery disease	8.53e-06	0.000122	CcSEcCtD
Naproxen—Vomiting—Captopril—coronary artery disease	8.53e-06	0.000122	CcSEcCtD
Naproxen—Dyspnoea—Lisinopril—coronary artery disease	8.47e-06	0.000122	CcSEcCtD
Naproxen—Rash—Captopril—coronary artery disease	8.46e-06	0.000121	CcSEcCtD
Naproxen—Dermatitis—Captopril—coronary artery disease	8.45e-06	0.000121	CcSEcCtD
Naproxen—Somnolence—Lisinopril—coronary artery disease	8.44e-06	0.000121	CcSEcCtD
Naproxen—Feeling abnormal—Timolol—coronary artery disease	8.44e-06	0.000121	CcSEcCtD
Naproxen—Headache—Captopril—coronary artery disease	8.4e-06	0.000121	CcSEcCtD
Naproxen—Gastrointestinal pain—Timolol—coronary artery disease	8.37e-06	0.00012	CcSEcCtD
Naproxen—Dizziness—Furosemide—coronary artery disease	8.37e-06	0.00012	CcSEcCtD
Naproxen—Dyspepsia—Lisinopril—coronary artery disease	8.36e-06	0.00012	CcSEcCtD
Naproxen—Diarrhoea—Losartan—coronary artery disease	8.36e-06	0.00012	CcSEcCtD
Naproxen—Nausea—Trandolapril—coronary artery disease	8.34e-06	0.00012	CcSEcCtD
Naproxen—Urticaria—Ramipril—coronary artery disease	8.32e-06	0.000119	CcSEcCtD
Naproxen—Nausea—Enalapril—coronary artery disease	8.31e-06	0.000119	CcSEcCtD
Naproxen—Vomiting—Perindopril—coronary artery disease	8.28e-06	0.000119	CcSEcCtD
Naproxen—Body temperature increased—Ramipril—coronary artery disease	8.28e-06	0.000119	CcSEcCtD
Naproxen—Abdominal pain—Ramipril—coronary artery disease	8.28e-06	0.000119	CcSEcCtD
Naproxen—Decreased appetite—Lisinopril—coronary artery disease	8.26e-06	0.000119	CcSEcCtD
Naproxen—Rash—Perindopril—coronary artery disease	8.21e-06	0.000118	CcSEcCtD
Naproxen—Dermatitis—Perindopril—coronary artery disease	8.2e-06	0.000118	CcSEcCtD
Naproxen—Gastrointestinal disorder—Lisinopril—coronary artery disease	8.2e-06	0.000118	CcSEcCtD
Naproxen—Nausea—Telmisartan—coronary artery disease	8.19e-06	0.000118	CcSEcCtD
Naproxen—Fatigue—Lisinopril—coronary artery disease	8.19e-06	0.000118	CcSEcCtD
Naproxen—Headache—Perindopril—coronary artery disease	8.16e-06	0.000117	CcSEcCtD
Naproxen—Urticaria—Timolol—coronary artery disease	8.13e-06	0.000117	CcSEcCtD
Naproxen—Pain—Lisinopril—coronary artery disease	8.12e-06	0.000117	CcSEcCtD
Naproxen—Constipation—Lisinopril—coronary artery disease	8.12e-06	0.000117	CcSEcCtD
Naproxen—Body temperature increased—Timolol—coronary artery disease	8.09e-06	0.000116	CcSEcCtD
Naproxen—Abdominal pain—Timolol—coronary artery disease	8.09e-06	0.000116	CcSEcCtD
Naproxen—Dizziness—Losartan—coronary artery disease	8.08e-06	0.000116	CcSEcCtD
Naproxen—Vomiting—Furosemide—coronary artery disease	8.05e-06	0.000116	CcSEcCtD
Naproxen—Rash—Furosemide—coronary artery disease	7.98e-06	0.000115	CcSEcCtD
Naproxen—Dermatitis—Furosemide—coronary artery disease	7.97e-06	0.000115	CcSEcCtD
Naproxen—Nausea—Captopril—coronary artery disease	7.97e-06	0.000114	CcSEcCtD
Naproxen—Headache—Furosemide—coronary artery disease	7.93e-06	0.000114	CcSEcCtD
Naproxen—Feeling abnormal—Lisinopril—coronary artery disease	7.83e-06	0.000112	CcSEcCtD
Naproxen—Gastrointestinal pain—Lisinopril—coronary artery disease	7.77e-06	0.000112	CcSEcCtD
Naproxen—Vomiting—Losartan—coronary artery disease	7.77e-06	0.000112	CcSEcCtD
Naproxen—Nausea—Perindopril—coronary artery disease	7.73e-06	0.000111	CcSEcCtD
Naproxen—Hypersensitivity—Ramipril—coronary artery disease	7.72e-06	0.000111	CcSEcCtD
Naproxen—Rash—Losartan—coronary artery disease	7.7e-06	0.000111	CcSEcCtD
Naproxen—Dermatitis—Losartan—coronary artery disease	7.69e-06	0.00011	CcSEcCtD
Naproxen—Headache—Losartan—coronary artery disease	7.65e-06	0.00011	CcSEcCtD
Naproxen—Urticaria—Lisinopril—coronary artery disease	7.55e-06	0.000108	CcSEcCtD
Naproxen—Hypersensitivity—Timolol—coronary artery disease	7.54e-06	0.000108	CcSEcCtD
Naproxen—Nausea—Furosemide—coronary artery disease	7.52e-06	0.000108	CcSEcCtD
Naproxen—Asthenia—Ramipril—coronary artery disease	7.51e-06	0.000108	CcSEcCtD
Naproxen—Abdominal pain—Lisinopril—coronary artery disease	7.51e-06	0.000108	CcSEcCtD
Naproxen—Body temperature increased—Lisinopril—coronary artery disease	7.51e-06	0.000108	CcSEcCtD
Naproxen—Pruritus—Ramipril—coronary artery disease	7.41e-06	0.000106	CcSEcCtD
Naproxen—Asthenia—Timolol—coronary artery disease	7.35e-06	0.000105	CcSEcCtD
Naproxen—Nausea—Losartan—coronary artery disease	7.26e-06	0.000104	CcSEcCtD
Naproxen—Pruritus—Timolol—coronary artery disease	7.24e-06	0.000104	CcSEcCtD
Naproxen—Diarrhoea—Ramipril—coronary artery disease	7.17e-06	0.000103	CcSEcCtD
Naproxen—Diarrhoea—Timolol—coronary artery disease	7.01e-06	0.000101	CcSEcCtD
Naproxen—Hypersensitivity—Lisinopril—coronary artery disease	7e-06	0.0001	CcSEcCtD
Naproxen—Dizziness—Ramipril—coronary artery disease	6.93e-06	9.95e-05	CcSEcCtD
Naproxen—Asthenia—Lisinopril—coronary artery disease	6.81e-06	9.79e-05	CcSEcCtD
Naproxen—Dizziness—Timolol—coronary artery disease	6.77e-06	9.72e-05	CcSEcCtD
Naproxen—Pruritus—Lisinopril—coronary artery disease	6.72e-06	9.65e-05	CcSEcCtD
Naproxen—Vomiting—Ramipril—coronary artery disease	6.66e-06	9.56e-05	CcSEcCtD
Naproxen—Rash—Ramipril—coronary artery disease	6.6e-06	9.48e-05	CcSEcCtD
Naproxen—Dermatitis—Ramipril—coronary artery disease	6.6e-06	9.47e-05	CcSEcCtD
Naproxen—Headache—Ramipril—coronary artery disease	6.56e-06	9.42e-05	CcSEcCtD
Naproxen—Vomiting—Timolol—coronary artery disease	6.51e-06	9.35e-05	CcSEcCtD
Naproxen—Diarrhoea—Lisinopril—coronary artery disease	6.5e-06	9.33e-05	CcSEcCtD
Naproxen—Rash—Timolol—coronary artery disease	6.46e-06	9.27e-05	CcSEcCtD
Naproxen—Dermatitis—Timolol—coronary artery disease	6.45e-06	9.26e-05	CcSEcCtD
Naproxen—Headache—Timolol—coronary artery disease	6.41e-06	9.21e-05	CcSEcCtD
Naproxen—Dizziness—Lisinopril—coronary artery disease	6.28e-06	9.02e-05	CcSEcCtD
Naproxen—Nausea—Ramipril—coronary artery disease	6.22e-06	8.93e-05	CcSEcCtD
Naproxen—Nausea—Timolol—coronary artery disease	6.08e-06	8.73e-05	CcSEcCtD
Naproxen—Vomiting—Lisinopril—coronary artery disease	6.04e-06	8.67e-05	CcSEcCtD
Naproxen—Rash—Lisinopril—coronary artery disease	5.99e-06	8.6e-05	CcSEcCtD
Naproxen—Dermatitis—Lisinopril—coronary artery disease	5.98e-06	8.59e-05	CcSEcCtD
Naproxen—Headache—Lisinopril—coronary artery disease	5.95e-06	8.54e-05	CcSEcCtD
Naproxen—Nausea—Lisinopril—coronary artery disease	5.64e-06	8.1e-05	CcSEcCtD
Naproxen—CYP2C8—Metabolism—CTGF—coronary artery disease	1.31e-06	4.2e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—LPA—coronary artery disease	1.3e-06	4.18e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—CTGF—coronary artery disease	1.3e-06	4.18e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—HMGCR—coronary artery disease	1.3e-06	4.16e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GOT2—coronary artery disease	1.3e-06	4.16e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—GOT2—coronary artery disease	1.29e-06	4.14e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—HMGCR—coronary artery disease	1.29e-06	4.14e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—DCN—coronary artery disease	1.28e-06	4.1e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—MTHFR—coronary artery disease	1.26e-06	4.06e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PLCB3—coronary artery disease	1.26e-06	4.05e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PPARG—coronary artery disease	1.26e-06	4.04e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—PPP2CA—coronary artery disease	1.25e-06	4.01e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOA5—coronary artery disease	1.25e-06	4e-05	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	1.25e-06	4e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ALDH2—coronary artery disease	1.24e-06	3.99e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—POMC—coronary artery disease	1.24e-06	3.98e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GSTP1—coronary artery disease	1.24e-06	3.97e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—PRKCD—coronary artery disease	1.23e-06	3.94e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PPARGC1A—coronary artery disease	1.22e-06	3.93e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—P4HB—coronary artery disease	1.22e-06	3.93e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—VEGFA—coronary artery disease	1.22e-06	3.92e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—HMOX1—coronary artery disease	1.22e-06	3.91e-05	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PTGS2—coronary artery disease	1.22e-06	3.91e-05	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ALB—coronary artery disease	1.21e-06	3.89e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.21e-06	3.89e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.21e-06	3.89e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—LIPC—coronary artery disease	1.21e-06	3.88e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—HBA1—coronary artery disease	1.21e-06	3.88e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	1.21e-06	3.88e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP2C19—coronary artery disease	1.21e-06	3.88e-05	CbGpPWpGaD
Naproxen—AKR1C3—Disease—IL6—coronary artery disease	1.2e-06	3.87e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CAT—coronary artery disease	1.2e-06	3.86e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—APOC3—coronary artery disease	1.2e-06	3.86e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—AGT—coronary artery disease	1.2e-06	3.86e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	1.2e-06	3.86e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—MTHFR—coronary artery disease	1.2e-06	3.85e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—LDLR—coronary artery disease	1.19e-06	3.84e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.19e-06	3.83e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PLCB1—coronary artery disease	1.19e-06	3.83e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.19e-06	3.81e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PLCB1—coronary artery disease	1.19e-06	3.81e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GSTT1—coronary artery disease	1.18e-06	3.79e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—SLC9A1—coronary artery disease	1.18e-06	3.79e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—APOE—coronary artery disease	1.18e-06	3.78e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.17e-06	3.77e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.17e-06	3.76e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—APOB—coronary artery disease	1.17e-06	3.75e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GCLC—coronary artery disease	1.17e-06	3.75e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CETP—coronary artery disease	1.17e-06	3.75e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—APOA1—coronary artery disease	1.16e-06	3.74e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.16e-06	3.73e-05	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—NOS3—coronary artery disease	1.16e-06	3.72e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ABCA1—coronary artery disease	1.16e-06	3.71e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—SDC1—coronary artery disease	1.15e-06	3.7e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—ABCA1—coronary artery disease	1.15e-06	3.69e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—HIF1A—coronary artery disease	1.14e-06	3.67e-05	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—PIK3CA—coronary artery disease	1.14e-06	3.66e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GSTM1—coronary artery disease	1.14e-06	3.65e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—VCAN—coronary artery disease	1.13e-06	3.63e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ALB—coronary artery disease	1.13e-06	3.63e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ALDOA—coronary artery disease	1.12e-06	3.61e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—TGFB1—coronary artery disease	1.12e-06	3.6e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GOT1—coronary artery disease	1.12e-06	3.59e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GGT1—coronary artery disease	1.12e-06	3.59e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—APOE—coronary artery disease	1.12e-06	3.58e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—LPL—coronary artery disease	1.11e-06	3.58e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.11e-06	3.58e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—GGT1—coronary artery disease	1.11e-06	3.57e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—GOT1—coronary artery disease	1.11e-06	3.57e-05	CbGpPWpGaD
Naproxen—AKR1C3—Disease—AKT1—coronary artery disease	1.11e-06	3.57e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—APOA1—coronary artery disease	1.1e-06	3.54e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—MAPK1—coronary artery disease	1.1e-06	3.53e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—DCN—coronary artery disease	1.09e-06	3.5e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PSMA6—coronary artery disease	1.09e-06	3.5e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PSMB5—coronary artery disease	1.09e-06	3.5e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.09e-06	3.49e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GPX1—coronary artery disease	1.09e-06	3.49e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—NOS3—coronary artery disease	1.08e-06	3.47e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CTGF—coronary artery disease	1.06e-06	3.42e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ALDH2—coronary artery disease	1.06e-06	3.41e-05	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PTGS2—coronary artery disease	1.06e-06	3.4e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CD36—coronary artery disease	1.06e-06	3.4e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—HMGCR—coronary artery disease	1.06e-06	3.39e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GOT2—coronary artery disease	1.06e-06	3.39e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IL6ST—coronary artery disease	1.05e-06	3.36e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PPP2CA—coronary artery disease	1.05e-06	3.36e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—NOS2—coronary artery disease	1.04e-06	3.34e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.03e-06	3.32e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYP2C19—coronary artery disease	1.03e-06	3.32e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	1.03e-06	3.32e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—HBA1—coronary artery disease	1.03e-06	3.32e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—LIPC—coronary artery disease	1.03e-06	3.32e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOC3—coronary artery disease	1.03e-06	3.3e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PPARG—coronary artery disease	1.02e-06	3.29e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—LDLR—coronary artery disease	1.02e-06	3.28e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.02e-06	3.27e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—POMC—coronary artery disease	1.01e-06	3.25e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SLC9A1—coronary artery disease	1.01e-06	3.24e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GSTT1—coronary artery disease	1.01e-06	3.24e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—KIT—coronary artery disease	1.01e-06	3.23e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—VEGFA—coronary artery disease	1.01e-06	3.23e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GSTP1—coronary artery disease	1.01e-06	3.23e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—MTHFR—coronary artery disease	1e-06	3.22e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—GSTP1—coronary artery disease	1e-06	3.21e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CETP—coronary artery disease	9.97e-07	3.2e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GCLC—coronary artery disease	9.97e-07	3.2e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	9.96e-07	3.2e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—HMOX1—coronary artery disease	9.91e-07	3.18e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PPARGC1A—coronary artery disease	9.9e-07	3.18e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PTGS2—coronary artery disease	9.89e-07	3.18e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SDC1—coronary artery disease	9.86e-07	3.17e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—HMOX1—coronary artery disease	9.86e-07	3.17e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CAT—coronary artery disease	9.78e-07	3.14e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—CAT—coronary artery disease	9.73e-07	3.12e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PLCB1—coronary artery disease	9.7e-07	3.12e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—GSK3B—coronary artery disease	9.66e-07	3.1e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—CREB1—coronary artery disease	9.58e-07	3.08e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—AGT—coronary artery disease	9.53e-07	3.06e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—PIK3CA—coronary artery disease	9.53e-07	3.06e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	9.52e-07	3.06e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—APOB—coronary artery disease	9.5e-07	3.05e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—APOB—coronary artery disease	9.44e-07	3.03e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ABCA1—coronary artery disease	9.4e-07	3.02e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IL6R—coronary artery disease	9.35e-07	3e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—APOE—coronary artery disease	9.34e-07	3e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PSMA6—coronary artery disease	9.31e-07	2.99e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PSMB5—coronary artery disease	9.31e-07	2.99e-05	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—AKT1—coronary artery disease	9.31e-07	2.99e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	9.3e-07	2.99e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GSTM1—coronary artery disease	9.24e-07	2.97e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—APOA1—coronary artery disease	9.23e-07	2.97e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—TGFB1—coronary artery disease	9.23e-07	2.97e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ALB—coronary artery disease	9.22e-07	2.96e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—GSTM1—coronary artery disease	9.19e-07	2.95e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GOT1—coronary artery disease	9.11e-07	2.92e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GGT1—coronary artery disease	9.11e-07	2.92e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CTGF—coronary artery disease	9.1e-07	2.92e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—LPL—coronary artery disease	9.07e-07	2.91e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—MAPK1—coronary artery disease	9.06e-07	2.91e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GOT2—coronary artery disease	9.02e-07	2.9e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—HMGCR—coronary artery disease	9.02e-07	2.9e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—LPL—coronary artery disease	9.02e-07	2.9e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GPX1—coronary artery disease	8.85e-07	2.84e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	8.84e-07	2.84e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—NOS3—coronary artery disease	8.82e-07	2.83e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—GPX1—coronary artery disease	8.8e-07	2.82e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—SERPINE1—coronary artery disease	8.75e-07	2.81e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CD36—coronary artery disease	8.62e-07	2.77e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—CD36—coronary artery disease	8.57e-07	2.75e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PPP2CA—coronary artery disease	8.51e-07	2.73e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—FGF2—coronary artery disease	8.47e-07	2.72e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PPP2CA—coronary artery disease	8.46e-07	2.72e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL6—coronary artery disease	8.44e-07	2.71e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—NOS3—coronary artery disease	8.36e-07	2.68e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PLCB1—coronary artery disease	8.29e-07	2.66e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GSTP1—coronary artery disease	8.18e-07	2.63e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—MTHFR—coronary artery disease	8.16e-07	2.62e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PPARG—coronary artery disease	8.14e-07	2.61e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	8.13e-07	2.61e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—JAK2—coronary artery disease	8.12e-07	2.61e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—MTHFR—coronary artery disease	8.12e-07	2.61e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	8.11e-07	2.6e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—HMOX1—coronary artery disease	8.07e-07	2.59e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PTGS2—coronary artery disease	8.06e-07	2.59e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ABCA1—coronary artery disease	8.04e-07	2.58e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—POMC—coronary artery disease	8.02e-07	2.58e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CAT—coronary artery disease	7.96e-07	2.56e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—PIK3CA—coronary artery disease	7.86e-07	2.52e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—AKT1—coronary artery disease	7.78e-07	2.5e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GGT1—coronary artery disease	7.78e-07	2.5e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GOT1—coronary artery disease	7.78e-07	2.5e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—AGT—coronary artery disease	7.76e-07	2.49e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—APOB—coronary artery disease	7.73e-07	2.48e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—AGT—coronary artery disease	7.71e-07	2.48e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—APOE—coronary artery disease	7.6e-07	2.44e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—APOE—coronary artery disease	7.56e-07	2.43e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GSTM1—coronary artery disease	7.52e-07	2.41e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—APOA1—coronary artery disease	7.51e-07	2.41e-05	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PIK3CA—coronary artery disease	7.49e-07	2.4e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—APOA1—coronary artery disease	7.47e-07	2.4e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—LPL—coronary artery disease	7.38e-07	2.37e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ALB—coronary artery disease	7.32e-07	2.35e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GPX1—coronary artery disease	7.2e-07	2.31e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	7.19e-07	2.31e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	7.15e-07	2.3e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CD36—coronary artery disease	7.01e-07	2.25e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—NOS3—coronary artery disease	7e-07	2.25e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GSTP1—coronary artery disease	6.99e-07	2.25e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	6.93e-07	2.22e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PPP2CA—coronary artery disease	6.92e-07	2.22e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—HMOX1—coronary artery disease	6.9e-07	2.21e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CAT—coronary artery disease	6.8e-07	2.18e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—MTHFR—coronary artery disease	6.64e-07	2.13e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PPARG—coronary artery disease	6.62e-07	2.13e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOB—coronary artery disease	6.6e-07	2.12e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PPARG—coronary artery disease	6.58e-07	2.11e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—POMC—coronary artery disease	6.53e-07	2.1e-05	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PIK3CA—coronary artery disease	6.52e-07	2.09e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—POMC—coronary artery disease	6.49e-07	2.08e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GSTM1—coronary artery disease	6.42e-07	2.06e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—AKT1—coronary artery disease	6.42e-07	2.06e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—AGT—coronary artery disease	6.31e-07	2.03e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—LPL—coronary artery disease	6.31e-07	2.03e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—APOE—coronary artery disease	6.19e-07	1.99e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GPX1—coronary artery disease	6.15e-07	1.98e-05	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—AKT1—coronary artery disease	6.12e-07	1.96e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—APOA1—coronary artery disease	6.12e-07	1.96e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PIK3CA—coronary artery disease	6.09e-07	1.95e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CD36—coronary artery disease	5.99e-07	1.92e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ALB—coronary artery disease	5.95e-07	1.91e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PPP2CA—coronary artery disease	5.92e-07	1.9e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5.86e-07	1.88e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—NOS3—coronary artery disease	5.69e-07	1.83e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—MTHFR—coronary artery disease	5.68e-07	1.82e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—NOS3—coronary artery disease	5.66e-07	1.82e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—TGFB1—coronary artery disease	5.53e-07	1.77e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—MAPK1—coronary artery disease	5.42e-07	1.74e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—AGT—coronary artery disease	5.4e-07	1.73e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PPARG—coronary artery disease	5.39e-07	1.73e-05	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—AKT1—coronary artery disease	5.33e-07	1.71e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—POMC—coronary artery disease	5.31e-07	1.71e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOE—coronary artery disease	5.29e-07	1.7e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOA1—coronary artery disease	5.23e-07	1.68e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PTGS2—coronary artery disease	5.21e-07	1.67e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PTGS2—coronary artery disease	5.18e-07	1.66e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5e-07	1.61e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—AKT1—coronary artery disease	4.97e-07	1.6e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PIK3CA—coronary artery disease	4.96e-07	1.59e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ALB—coronary artery disease	4.84e-07	1.56e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—PIK3CA—coronary artery disease	4.7e-07	1.51e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NOS3—coronary artery disease	4.63e-07	1.49e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PPARG—coronary artery disease	4.6e-07	1.48e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—POMC—coronary artery disease	4.54e-07	1.46e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PTGS2—coronary artery disease	4.24e-07	1.36e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IL6—coronary artery disease	4.16e-07	1.34e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ALB—coronary artery disease	4.14e-07	1.33e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—AKT1—coronary artery disease	4.05e-07	1.3e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NOS3—coronary artery disease	3.96e-07	1.27e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PIK3CA—coronary artery disease	3.94e-07	1.26e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—AKT1—coronary artery disease	3.84e-07	1.23e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PTGS2—coronary artery disease	3.62e-07	1.16e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—AKT1—coronary artery disease	3.22e-07	1.03e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PIK3CA—coronary artery disease	3.2e-07	1.03e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PIK3CA—coronary artery disease	3.19e-07	1.02e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—AKT1—coronary artery disease	2.62e-07	8.41e-06	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PIK3CA—coronary artery disease	2.61e-07	8.37e-06	CbGpPWpGaD
Naproxen—ALB—Metabolism—AKT1—coronary artery disease	2.6e-07	8.36e-06	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PIK3CA—coronary artery disease	2.23e-07	7.16e-06	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—AKT1—coronary artery disease	2.13e-07	6.84e-06	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—AKT1—coronary artery disease	1.82e-07	5.85e-06	CbGpPWpGaD
